Acute and Postacute Clinical Characteristics of Coronavirus Disease 2019 in Children in Japan

Tomohiro Katsuta1,2, Yuta Aizawa3, Kensuke Shoji4

  • 1From the The Committee on Immunization and Infectious Diseases, Japan Pediatric Society, Japan.

Insights

Clinical features of coronavirus disease 2019 (COVID-19) in children evolved with variants of concern. A study in Japan found increased symptomatic cases and persistent symptoms, particularly during the Omicron variant period, highlighting the need for further research.

Area of Science:

  • Pediatric infectious diseases
  • Virology
  • Public health

Background:

  • Clinical features of COVID-19 in children have evolved due to variants of concern (VOC).
  • Increased VOC infections raise concerns about persistent symptoms in pediatric COVID-19 cases.
  • Understanding these changes is crucial for managing pediatric health during the pandemic.

Purpose of the Study:

  • To analyze clinical manifestations of pediatric COVID-19 in Japan.
  • To investigate persistent symptoms in children following COVID-19 infection.
  • To assess the impact of different SARS-CoV-2 variants on pediatric cases.

Main Methods:

  • Analysis of 5411 pediatric COVID-19 cases for clinical manifestations (Feb 2020-Apr 2022).
  • Analysis of 1697 pediatric COVID-19 cases for persistent symptoms (Feb 2020-Nov 2021).
  • Data collected via a dedicated database from the Japan Pediatric Society.

Main Results:

  • Seizure incidence increased significantly during the Omicron variant period (13.4% in 1-4 years, 7.4% in 5-11 years).
  • Persistent symptoms after 28 days were reported in 3.2% (55 cases) of pediatric patients.
  • Symptomatic cases increased, especially during the Omicron predominant period.

Conclusions:

  • Pediatric COVID-19 clinical features and symptom persistence vary with SARS-CoV-2 variants.
  • A notable percentage of children experience prolonged symptoms or severe complications.
  • Further longitudinal studies are necessary to monitor affected children.
Abstract

Related Concept Videos

Acute Pharyngitis01:30

Acute Pharyngitis

Introduction
Acute pharyngitis is the inflammation of the back of the throat (pharynx), commonly resulting in a sore throat. It is a frequently encountered condition that prompts individuals to seek medical advice.
Classification
Acute pharyngitis can be categorized based on its underlying cause:
1.2K
Acute Respiratory Failure-II01:21

Acute Respiratory Failure-II

Type I Respiratory Failure, or hypoxemic respiratory failure, occurs when the partial pressure of oxygen (PaO2) in arterial blood falls below 60 mmHg while breathing room air without a corresponding increase in arterial carbon dioxide levels (PaCO2). This condition highlights a significant impairment in the lungs' capacity to oxygenate the blood.
The underlying physiological abnormalities that contribute to hypoxemic respiratory failure include:
314
Acute Kidney Injury III: Clinical Manifestations01:29

Acute Kidney Injury III: Clinical Manifestations

Acute Kidney Injury (AKI) progresses through distinct clinical phases: the oliguric, diuretic, and recovery phases, each marked by unique manifestations and challenges.Oliguric Phase:The oliguric phase is the initial stage of AKI, typically lasting 10 to 14 days. This phase is marked by a significant reduction in urine output, usually less than 400 mL per day, indicating decreased kidney function. Fluid retention is a prominent feature, leading to symptoms such as edema, hypertension, and...
54
Acute Respiratory Failure-I01:21

Acute Respiratory Failure-I

Acute respiratory failure is a condition characterized by the inability of the lungs to perform their primary function: gas exchange. This failure leads to insufficient oxygen levels (hypoxemia) in the blood, elevated carbon dioxide levels (hypercapnia), or both, causing critical impairment in organ function.
Definition: It is defined by specific criteria based on blood gas measurements. Hypoxemia happens when the partial pressure of oxygen (PaO2) falls below 60 mmHg. At the same time,...
275
Acute Respiratory Failure-V01:29

Acute Respiratory Failure-V

The treatment for acute respiratory failure varies based on factors like the underlying cause, overall health, and severity. A collaborative healthcare team is essential for early detection, often through arterial blood gas analysis. Identifying the cause is the primary goal, with treatment strategies adjusted for ventilation/perfusion (V/Q) mismatch, shunting, or diffusion impairment.
Ensure that patients are monitored continuously for their response to therapy, including changes in...
178
Acute Respiratory Failure-III01:30

Acute Respiratory Failure-III

Hypercapnic respiratory failure, also known as Type 2 or ventilatory respiratory failure, is a severe condition characterized by the body's inability to effectively remove carbon dioxide (CO2) from the bloodstream. It leads to an arterial CO2 pressure (PaCO2) exceeding 45 mmHg and a blood pH above 7.35. This situation indicates that the body's ventilatory demand, or the ventilation needed to maintain normal PaCO2 levels, surpasses its supply or the maximum gas flow achievable without...
254